Pluto Biosciences, Inc

GSE112250: Promoter or enhancer activation by CRISPRa rescues haploinsufficiency caused obesity

Bulk RNA sequencing

Our results show that CRISPRa can be developed as a gene regulation therapy (GRT) to treat altered gene dosage diseases. SOURCE: Walter Eckalbar ( - University of California, San Francisco

View this experiment on Pluto Biosciences, Inc